Related Experiment Video
Updated: Jul 19, 2026

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
Published on: July 20, 2014
Connexin 32 expression reduces malignant phenotype in human A549 adenocarcinoma cells: Implication of Src involvement
Sachio Hada1, Hiromi Sato, Nantiga Virgona
1Department of Food Science Research for Health, National Institute of Health and Nutrition, Toyama, Tokyo 162-8636, Japan.
Abstract:
Recent evidence suggests that a member of the gap junction protein family, connexin (Cx) 32, acts as a tumor suppressor gene against lung adenocarcinoma. However, the precise mechanism remains unclear. In this study, we tried to explore the mechanism for the Cx32-dependent tumor-suppressive effect in lung adenocarcinoma. To perform this study, we established a stable clone of the human lung adenocarcinoma cell line, A549 in which the Cx32 gene was expressed. Cx32 expression in A549 cells reduced anchorage-independent growth and development of tumors in a xenograft model. Additionally, Cx32 induced contact inhibition of growth and reduced invasive activity in A549 cells. The tumor-suppressive effects of Cx32 depended on the inhibition of Src activity. These events were confirmed by an Src inhibitor (PP1) and siRNA for Cx32. These results suggest that the Cx32-dependent tumor-suppressive effect in A549 cells is explained by the inhibition of Src activity.
Insights
Connexin 32 (Cx32) suppresses lung adenocarcinoma by inhibiting Src activity. This gap junction protein reduces tumor growth, invasion, and anchorage-independent growth in A549 cells.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Lung adenocarcinoma is a major cause of cancer mortality.
- Connexin 32 (Cx32), a gap junction protein, is implicated as a potential tumor suppressor.
- The exact mechanism of Cx32's tumor-suppressive role in lung adenocarcinoma requires elucidation.
Purpose of the Study:
- To investigate the mechanism underlying the tumor-suppressive effects of Cx32 in lung adenocarcinoma.
- To determine if Cx32 inhibits Src activity in lung adenocarcinoma cells.
Main Methods:
- Established a stable A549 human lung adenocarcinoma cell line expressing Cx32.
- Assessed anchorage-independent growth and tumor development in a xenograft model.
- Utilized an Src inhibitor (PP1) and small interfering RNA (siRNA) targeting Cx32 for validation.
Main Results:
- Cx32 expression significantly reduced anchorage-independent growth and tumor formation in vivo.
- Cx32 induced contact inhibition of growth and decreased invasive capabilities of A549 cells.
- The tumor-suppressive effects of Cx32 were directly linked to the inhibition of Src activity.
Conclusions:
- Cx32 exerts tumor-suppressive effects in lung adenocarcinoma by inhibiting Src activity.
- Cx32 represents a potential therapeutic target for lung adenocarcinoma treatment.
- Understanding Cx32's mechanism provides insights into lung cancer progression.
Related Concept Videos
Abnormal Proliferation
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...